Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B.

about

Digital PCR as a tool to measure HIV persistence.Development of sensitive ddPCR assays to reliably quantify the proviral DNA reservoir in all common circulating HIV subtypes and recombinant forms

P2860

Q47548213-6C944862-7F91-4999-B3EF-EEA39540DEB8 Q58128506-BAE174DF-15CD-4C87-AAC7-7B40F9AB1A23

P2860

Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B.

Item

http://www.wikidata.org/entity/Q41929341

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Virological and immunological ...... ubjects vaccinated with MVA-B.

@en

type

Item

label

Virological and immunological ...... ubjects vaccinated with MVA-B.

@en

prefLabel

Virological and immunological ...... ubjects vaccinated with MVA-B.

@en

P1476

Virological and immunological ...... subjects vaccinated with MVA-B

@en

P2093

C Rodriguez

http://www.w3.org/2001/XMLSchema#string

Jose Luis Jímenez

http://www.w3.org/2001/XMLSchema#string

Mariano Esteban

http://www.w3.org/2001/XMLSchema#string

Núria Perez-Alvarez

http://www.w3.org/2001/XMLSchema#string

Patricia Cobarsí

http://www.w3.org/2001/XMLSchema#string

Rocío Bellido

http://www.w3.org/2001/XMLSchema#string

Roger Paredes

http://www.w3.org/2001/XMLSchema#string

P2860

Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection

Accurate whole human genome sequencing using reversible terminator chemistry

Sieve analysis in HIV-1 vaccine efficacy trials

MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods

DNA/MVA Vaccination of HIV-1 Infected Participants with Viral Suppression on Antiretroviral Therapy, followed by Treatment Interruption: Elicitation of Immune Responses without Control of Re-Emergent Virus

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

Fast and accurate long-read alignment with Burrows-Wheeler transform

Trimmomatic: a flexible trimmer for Illumina sequence data

Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection.

HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins.

P304

e0184929

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0184929

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Javier Martinez-Picado

P577

2017-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28953921

http://www.w3.org/2001/XMLSchema#string

P921

virology

P932

5617163

http://www.w3.org/2001/XMLSchema#string

Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B.

about

P2860

P2860

Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932